Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025.
about
Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP).Dolutegravir plus rilpivirine dual therapy in treating HIV-1 infection.Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART.Forecasting the global demand for HIV monitoring and diagnostic tests: A 2016-2021 analysis
P2860
Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025.
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Projected Uptake of New Antire ...... A Forecast Analysis 2015-2025.
@ast
Projected Uptake of New Antire ...... A Forecast Analysis 2015-2025.
@en
type
label
Projected Uptake of New Antire ...... A Forecast Analysis 2015-2025.
@ast
Projected Uptake of New Antire ...... A Forecast Analysis 2015-2025.
@en
prefLabel
Projected Uptake of New Antire ...... A Forecast Analysis 2015-2025.
@ast
Projected Uptake of New Antire ...... A Forecast Analysis 2015-2025.
@en
P2093
P2860
P1433
P1476
Projected Uptake of New Antire ...... A Forecast Analysis 2015-2025.
@en
P2093
Aastha Gupta
Boniface Dongmo Nguimfack
Daniel Low-Beer
Marco Vitoria
Meg Doherty
Sandeep Juneja
Vincent Habiyambere
P2860
P304
P356
10.1371/JOURNAL.PONE.0164619
P407
P577
2016-10-13T00:00:00Z